168 related articles for article (PubMed ID: 36597789)
1. β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia.
García-Hernández V; Arambilet D; Guillén Y; Lobo-Jarne T; Maqueda M; Gekas C; González J; Iglesias A; Vega-García N; Sentís I; Trincado JL; Márquez-López I; Heyn H; Camós M; Espinosa L; Bigas A
EMBO Mol Med; 2023 Feb; 15(2):e16554. PubMed ID: 36597789
[TBL] [Abstract][Full Text] [Related]
2. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia.
Bigas A; Guillén Y; Schoch L; Arambilet D
Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis.
Tan Y; Sementino E; Liu Z; Cai KQ; Testa JR
Sci Rep; 2020 Sep; 10(1):15837. PubMed ID: 32985581
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.
Dorfman DM; Greisman HA; Shahsafaei A
Am J Pathol; 2003 May; 162(5):1539-44. PubMed ID: 12707037
[TBL] [Abstract][Full Text] [Related]
5. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
[TBL] [Abstract][Full Text] [Related]
6. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
7. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
Kong D; Fan S; Sun L; Chen X; Zhao Y; Zhao L; Guo Z; Li Y
Hematol Oncol; 2021 Apr; 39(2):222-230. PubMed ID: 33300153
[TBL] [Abstract][Full Text] [Related]
9. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
Staal FJ; Burgering BM; van de Wetering M; Clevers HC
Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
[TBL] [Abstract][Full Text] [Related]
10. β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells.
Zhao X; Shao P; Gai K; Li F; Shan Q; Xue HH
Elife; 2020 Aug; 9():. PubMed ID: 32820720
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell leukemia virus type 1 tax dysregulates beta-catenin signaling.
Tomita M; Kikuchi A; Akiyama T; Tanaka Y; Mori N
J Virol; 2006 Nov; 80(21):10497-505. PubMed ID: 16920823
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.
Zhang Y; Lee S; Xu W
Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
[TBL] [Abstract][Full Text] [Related]
13. JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism.
Nath N; Chattopadhyay M; Pospishil L; Cieciura LZ; Goswami S; Kodela R; Saavedra JE; Keefer LK; Kashfi K
Biochem Pharmacol; 2010 Dec; 80(11):1641-9. PubMed ID: 20797387
[TBL] [Abstract][Full Text] [Related]
14. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
15. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
17. Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes.
Narasipura SD; Henderson LJ; Fu SW; Chen L; Kashanchi F; Al-Harthi L
J Virol; 2012 Feb; 86(4):1911-21. PubMed ID: 22156527
[TBL] [Abstract][Full Text] [Related]
18. IRS1/β-Catenin Axis Is Activated and Induces MYC Expression in Acute Lymphoblastic Leukemia Cells.
Fernandes JC; Rodrigues Alves APN; Machado-Neto JA; Scopim-Ribeiro R; Fenerich BA; da Silva FB; Simões BP; Rego EM; Traina F
J Cell Biochem; 2017 Jul; 118(7):1774-1781. PubMed ID: 27987331
[TBL] [Abstract][Full Text] [Related]
19. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression.
Prieve MG; Waterman ML
Mol Cell Biol; 1999 Jun; 19(6):4503-15. PubMed ID: 10330189
[TBL] [Abstract][Full Text] [Related]
20. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.
Yu S; Zhou X; Steinke FC; Liu C; Chen SC; Zagorodna O; Jing X; Yokota Y; Meyerholz DK; Mullighan CG; Knudson CM; Zhao DM; Xue HH
Immunity; 2012 Nov; 37(5):813-26. PubMed ID: 23103132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
